Brucellosis (undulant fever; Malta fever; Brucella melitensis/abortus)
Undulant fever + sweats + arthralgia + animal/raw-dairy contact; prolonged combination abx · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Zoonotic infection from Brucella via unpasteurised dairy, infected livestock or occupational exposure (farmers, vets, abattoir, lab). Protean: undulant fever, drenching sweats, arthralgia/back pain, hepatosplenomegaly; may become chronic/focal (sacroiliitis, spondylitis, epididymo-orchitis, endocarditis, neurobrucellosis). Needs prolonged COMBINATION antibiotics to prevent relapse. Endemic in India, Middle East, Mediterranean.
Red flags
- New murmur / heart failure - brucella endocarditis (main cause of death)
- Severe back pain with neurology - spondylitis / epidural involvement
- Headache, meningism, cranial neuropathy, behavioural change - neurobrucellosis
- Pancytopenia, pregnancy (miscarriage risk)
Assessment
Differential diagnosis
- Enteric fever, malaria, TB
- Lymphoma / haematological malignancy
- Connective tissue disease / vasculitis
- Infective endocarditis (other)
- Mechanical/TB back pain (vs brucellar spondylitis)
Investigations
- Blood cultures (prolonged incubation; alert lab to suspected Brucella - biohazard) +/- bone marrow culture (higher yield)
- Serology: Brucella agglutination (SAT) titre >=1:160 or rising; ELISA IgM/IgG
- FBC (cytopenias), LFTs (mild transaminitis), CRP/ESR
- Imaging for focal disease: MRI spine/sacroiliac joints; echocardiography if endocarditis suspected; LP if neurobrucellosis
- Inform laboratory (significant lab-acquisition risk - handle in containment)
Management
- Confirm with cultures/serology; warn the lab of biohazard
- Start prolonged combination antibiotic therapy (monotherapy relapses)
- Assess for focal/complicated disease (spondylitis, neurobrucellosis, endocarditis) - these need longer and/or triple therapy +/- surgery
- Counsel on source avoidance (pasteurise dairy, animal handling PPE); occupational/public-health notification where applicable
- Arrange prolonged follow-up (serology, clinical) to detect relapse
Drugs & doses
Uncomplicated (WHO/expert): doxycycline 100 mg PO BD 6 weeks + streptomycin 1 g IM OD 2-3 weeks (most effective) OR + gentamicin 5 mg/kg IV/IM OD 7-10 days
All-oral alternative: doxycycline 100 mg BD 6 weeks + rifampicin 600-900 mg PO OD 6 weeks (slightly higher relapse)
Spondylitis/sacroiliitis: doxycycline + rifampicin + an aminoglycoside (initial) for >=12 weeks [verify local]
Neurobrucellosis: doxycycline + rifampicin + ceftriaxone 2 g IV BD for months, until CSF normalises
Endocarditis: doxycycline + rifampicin + aminoglycoside +/- ceftriaxone, prolonged, usually with valve surgery
Children <8y / pregnancy: co-trimoxazole-based combinations (e.g. co-trimoxazole + rifampicin) - avoid doxycycline/aminoglycoside as able [verify local dose]
Disposition
Uncomplicated disease: outpatient oral/IM combination therapy with ID follow-up. Admit for complicated/focal disease (endocarditis, neurobrucellosis, severe spondylitis), systemic illness, or pregnancy. Long-term follow-up for relapse.
Complications & pitfalls
- Osteoarticular: sacroiliitis, spondylitis, peripheral arthritis
- Neurobrucellosis (meningoencephalitis, radiculopathy)
- Endocarditis (leading cause of brucellosis death)
- Epididymo-orchitis, hepatosplenic abscess
- Chronic brucellosis / relapse
- Pregnancy loss
Exam pearls
- Ask about unpasteurised dairy and animal/occupational contact in undulant fever with sweats and arthralgia
- Monotherapy relapses - always use a combination for >=6 weeks (longer for focal disease)
- Doxycycline + aminoglycoside outperforms doxycycline + rifampicin for relapse (Cochrane)
- Alert the laboratory - Brucella is a notorious cause of laboratory-acquired infection
- Suspect and specifically treat endocarditis, spondylitis and neurobrucellosis - they need intensified, prolonged therapy +/- surgery
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.